ILK-IN-3 is an orally active integrin linked kinase (ILK) inhibitor. ILK-IN-3 improves the anticancer efficacy of Docetaxel (HY-B0011) in orthotopic LCC6 model[1][2].
Molecular Weight:
232.24
Purity:
99.62
CAS Number:
[6975-75-3]
Formula:
C10H12N6O
Target:
Ser/Thr Kinase
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted